What Investors Need to Know About the Budget Reconciliation Bill
The bill could mean sweeping changes for regulatory oversight, tax incentives, and more.

As Congress moves forward with President Donald Trump’s sweeping policy bill, corporations across the country are bracing for a wave of regulatory and tax policy changes that could significantly reshape their operations and profitability.
The budget bill cleared the Senate on a 51-50 vote under a legislative process known as reconciliation. This process allows certain budget-related bills to bypass the Senate filibuster and pass with a simple majority. In this case, the vice president delivered the tiebreaking vote.
The Senate version of the bill includes an array of tax and policy changes that we’re still reviewing. Several provisions would likely have profound implications for banks, investment firms, insurance companies, and other financial-services providers.
The bill now goes back to the House, which passed its own version on May 22, 2025.
Here’s what investors should know about what was in the House version as we continue to review the Senate bill and its potential impact.
What’s in the Senate-Passed Reconciliation Bill?
The most closely watched elements of the Senate-passed version of the legislation cover:
- Deregulation: The Senate bill includes several measures that would loosen regulatory oversight over corporations across a variety of industries. For example, this proposal includes reforms that would accelerate and expand permitting for fossil fuel projects, pipelines, and mining operations. It would also roll back investor protections by slashing the Consumer Financial Protection Bureau’s budget.
- Elimination of clean energy credits: The bill also includes an accelerated phaseout of clean energy tax incentives established under the Inflation Reduction Act. It would end tax credits for the production of wind and solar projects placed in service after the end of 2027.
- Research and development incentives: The bill reinstates immediate expensing for research and development costs incurred within the United States, reversing changes made in previous tax legislation. This provision is expected to significantly benefit technology companies, pharmaceutical firms, and other innovation-driven sectors by improving their cash flow and encouraging continued investment in R&D.
What the Reconciliation Bill Means for Investors
If Congress passes the Senate-passed version, it will affect investors in a variety of ways.
On the positive side, the research and development incentives will increase aftertax profits for many companies, likely boosting stock valuations in sectors where research and development costs are high (for example, biotechnology, manufacturing, and software development). The bill also proposes wholesale changes to the environmental permitting process that will make permit acquisition easier for critical energy and mineral projects, ultimately providing a boost to these sectors.
That said, several notable provisions present significant risks for investors.
The Consumer Financial Protection Bureau is a key source of data and analysis of the consumer markets, and the proposed cuts to the CFPB would considerably reduce the quantity and quality of financial information that investors can access.
The elimination of clean energy credits will also significantly affect businesses that rely on them. In turn, this will affect investors, particularly those with portfolios focused on climate, sustainable infrastructure, and energy transition.
Moreover, institutional investors will likely reallocate away from environmental, social, and governance strategies as they become even more politically vulnerable, which will have a cascading effect for investors involved in ESG funds.
Where Does the Reconciliation Bill Go From Here?
Now that the Senate has passed its own version of the reconciliation, it will go back to the House for final approval. There are some notable discrepancies between the two bills that will need to be reconciled before the final version passes through both chambers of Congress and heads to the president’s desk.
Legislative experts suggest that the bill’s timeline could extend beyond the self-imposed July 4 deadline. Key swing votes will likely demand additional provisions or modifications, potentially altering the bill’s final impact on various sectors and investment strategies.
As the process unfolds, stakeholders across Wall Street and Main Street are watching closely, knowing that the decisions made in the coming weeks could reverberate through balance sheets, investment portfolios, and client strategies for years to come.
The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar’s editorial policies.
